BOSTON, Nov. 8, 2021 /PRNewswire/ -- Today, Ginkgo
Bioworks (NYSE: DNA), the leading horizontal platform for cell
programming, announced that it plans to host a presentation and
Q&A session reviewing business performance for the third
quarter ended September 30, 2021, on
Monday, November 15, 2021, beginning
at 8:00 a.m. ET.
The presentation details and registration link will be available
on Ginkgo's investor relations website at
www.ginkgobioworks.com/investors and a replay will be made
To ask a question ahead of the presentation, please submit them
to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an
e-mail to email@example.com.
About Ginkgo Bioworks
Ginkgo is building a platform to enable customers to program
cells as easily as we can program computers. The company's platform
is enabling biotechnology applications across diverse markets, from
food and agriculture to industrial chemicals to pharmaceuticals.
Ginkgo has also actively supported a number of COVID-19 response
efforts, including K-12 pooled testing, vaccine manufacturing
optimization and therapeutics discovery. For more information,
Ginkgo Bioworks Contacts:
View original content to download
SOURCE Ginkgo Bioworks